Cardiovascular medicine
Citations 3241-3250 of 25899 total displayed.
Past content
(since Oct 1840):
|
-
- Feature
- Rosiglitazone, marketing, and medical science
- Ray Moynihan
-
BMJ 2010;340:c1848, doi: 10.1136/bmj.c1848,
-
[Extract]
[Full text]
-
- Feature
- Rosiglitazone in the UK: down but not out
- Ike Iheanacho
-
BMJ 2010;340:c1849, doi: 10.1136/bmj.c1849,
-
[Extract]
[Full text]
-
- News
- Primary care must have greater role in Chinas health system, says OECD
- John Zarocostas
-
BMJ 2010;340:c1903, doi: 10.1136/bmj.c1903,
-
[Extract]
[Full text]
-
- Analysis
- How to identify when a performance indicator has run its course
- David Reeves, Tim Doran, Jose M Valderas, Evangelos Kontopantelis, Paul Trueman, Matt Sutton, Stephen Campbell, and Helen Lester
-
BMJ 2010;340:c1717, doi: 10.1136/bmj.c1717,
-
[Extract]
[Full text]
-
- Editorials
- Wellbeing in the workplace
- Michael F Roizen and Keith W Roach
-
BMJ 2010;340:c1743, doi: 10.1136/bmj.c1743,
-
[Extract]
[Full text]
-
- Editorials
- Diagnosing colorectal cancer in primary care
- David Weller
-
BMJ 2010;340:c1714, doi: 10.1136/bmj.c1714,
-
[Extract]
[Full text]
-
- Endgames
- An agitated young man
- Farhana Mann and Anna Sobel
-
BMJ 2010;340:c732, doi: 10.1136/bmj.c732,
-
[Extract]
[Full text]
-
- Endgames
- Immunocompromised patient with an ulcerated nasolabial skin lesion
- Emmanuel P Prokopakis, Irene E Panagiotaki, Ioannis A Papadakis, Alexios S Vardouniotis, George M Lagoudianakis, and George A Velegrakis
-
BMJ 2010;340:c1444, doi: 10.1136/bmj.c1444,
-
[Extract]
[Full text]
-
- Research Methods & Reporting
- Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
- Xin Sun, Matthias Briel, Stephen D Walter, and Gordon H Guyatt
-
BMJ 2010;340:c117, doi: 10.1136/bmj.c117,
-
[Full text]
-
- News
- Doctors no longer have to use Framingham equation to assessheart disease risk, NICE says
- Susan Mayor
-
BMJ 2010;340:c1774, doi: 10.1136/bmj.c1774,
-
[Extract]
[Full text]
|